More Australian Clinical Labs Ltd news
Australian Clinical Labs LtdASX: ACL

Third Supplementary Bidder's Statement

Oct 8, 2023 at 10:55 PM EDT · Issued by Australian Clinical Labs Ltd

Filed with ASX · Oct 8, 2023 at 10:55 PM EDT

On 6ix: 6ix.com/news/third-supplementary-bidders-statement-4

Australian Clinical Labs Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Australian Clinical Labs Ltd on 6ix

Story so far

  • Second Supplementary Bidder's StatementMay 22, 2023
  • First Supplementary Bidder's StatementApr 14, 2023

Earlier from Australian Clinical Labs

  • HLS: Supplementary Target's StatementSep 4, 2023
  • FY23 investor results presentationAug 21, 2023
  • Appendix 4E and FY23 financial reportsAug 21, 2023
  • HLS: ACCC Statement of IssuesJul 20, 2023
  • Takeover bid for Healius Ltd- extension of offer periodJul 20, 2023

Later from Australian Clinical Labs

  • Notice of fulfilment of conditionsOct 8, 2023
  • Takeover offer for Healius - extension of offer periodOct 31, 2023
  • Extension of offer period - notice of variationOct 31, 2023
  • Fourth Supplementary Bidder's StatementNov 9, 2023
  • Takeover offer - Healius entitlement offerNov 20, 2023
All Australian Clinical Labs news releases↗

Follow Australian Clinical Labs into a list and get an email when it puts out news.

Follow Australian Clinical Labs
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer